BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24657055)

  • 1. E-prescribing errors in community pharmacies: exploring consequences and contributing factors.
    Odukoya OK; Stone JA; Chui MA
    Int J Med Inform; 2014 Jun; 83(6):427-37. PubMed ID: 24657055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. e-Prescribing: characterisation of patient safety hazards in community pharmacies using a sociotechnical systems approach.
    Odukoya OK; Chui MA
    BMJ Qual Saf; 2013 Oct; 22(10):816-25. PubMed ID: 23708439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E-prescribing errors identified in a compounding pharmacy: a quality-improvement project.
    Reed-Kane D; Kittell K; Adkins J; Flocks S; Nguyen T
    Int J Pharm Compd; 2014; 18(1):83-6. PubMed ID: 24881345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers and facilitators to recovering from e-prescribing errors in community pharmacies.
    Odukoya OK; Stone JA; Chui MA
    J Am Pharm Assoc (2003); 2015; 55(1):52-8. PubMed ID: 25539495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How do community pharmacies recover from e-prescription errors?
    Odukoya OK; Stone JA; Chui MA
    Res Social Adm Pharm; 2014; 10(6):837-852. PubMed ID: 24373898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between e-prescriptions and community pharmacy workflow.
    Odukoya OK; Chui MA
    J Am Pharm Assoc (2003); 2012; 52(6):e168-74. PubMed ID: 23229979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of e-prescribing in chain community pharmacy: best-practice recommendations.
    Rupp MT; Warholak TL
    J Am Pharm Assoc (2003); 2008; 48(3):364-70. PubMed ID: 18595821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of community chain pharmacists' interventions on electronic prescriptions.
    Warholak TL; Rupp MT
    J Am Pharm Assoc (2003); 2009; 49(1):59-64. PubMed ID: 19196598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of pharmacists' interventions on electronic versus traditional prescriptions in 2 community pharmacies.
    Gilligan AM; Miller K; Mohney A; Montenegro C; Schwarz J; Warholak TL
    Res Social Adm Pharm; 2012; 8(6):523-32. PubMed ID: 22264963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retail pharmacy staff perceptions of design strengths and weaknesses of electronic prescribing.
    Odukoya O; Chui MA
    J Am Med Inform Assoc; 2012; 19(6):1059-65. PubMed ID: 22753809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Quantitative and Qualitative Analysis of Electronic Prescribing Incidents Reported by Community Pharmacists.
    Hincapie AL; Alamer A; Sears J; Warholak TL; Goins S; Weinstein SD
    Appl Clin Inform; 2019 May; 10(3):387-394. PubMed ID: 31167250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E-prescription errors and their resolution in a community compounding pharmacy.
    Reed-Kane D; Vasquez K; Pavlik A; Peragine J; Sandberg M
    Int J Pharm Compd; 2014; 18(2):159-61. PubMed ID: 24881120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing automated product selection success rates in transmissions between electronic prescribing and community pharmacy platforms.
    Panich J; Larson N; Sojka L; Wallace Z; Lokken J
    J Am Med Inform Assoc; 2021 Jan; 28(1):113-118. PubMed ID: 33186450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of electronic prescription transmission to computerized prescriber order entry: Effect on dispensing errors in community pharmacies.
    Moniz TT; Seger AC; Keohane CA; Seger DL; Bates DW; Rothschild JM
    Am J Health Syst Pharm; 2011 Jan; 68(2):158-63. PubMed ID: 21200064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality and Variability of Patient Directions in Electronic Prescriptions in the Ambulatory Care Setting.
    Yang Y; Ward-Charlerie S; Dhavle AA; Rupp MT; Green J
    J Manag Care Spec Pharm; 2018 Jul; 24(7):691-699. PubMed ID: 29345553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges of standardized continuous quality improvement programs in community pharmacies: the case of SafetyNET-Rx.
    Boyle TA; MacKinnon NJ; Mahaffey T; Duggan K; Dow N
    Res Social Adm Pharm; 2012; 8(6):499-508. PubMed ID: 22421196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of electronic prescriptions on medication safety in Finnish community pharmacies: A survey of pharmacists.
    Kauppinen H; Ahonen R; Timonen J
    Int J Med Inform; 2017 Apr; 100():56-62. PubMed ID: 28241938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keeping the "continuous" in continuous quality improvement: exploring perceived outcomes of CQI program use in community pharmacy.
    Boyle TA; Bishop AC; Duggan K; Reid C; Mahaffey T; MacKinnon NJ; Mahaffey A
    Res Social Adm Pharm; 2014; 10(1):45-57. PubMed ID: 23528447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causes and consequences of e-prescribing errors in community pharmacies.
    Abramson EL
    Integr Pharm Res Pract; 2015; 5():31-38. PubMed ID: 29354537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacy communications with physician offices to clarify prescriptions.
    Smith M; Sprecher B
    J Am Pharm Assoc (2003); 2017; 57(2):178-182. PubMed ID: 28161301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.